NEW YORK, Jan. 5, 2022 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Jupiter Wellness, Inc. JUPW
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Jupiter Wellness, Inc. JUPW, in connection with the proposed merger of the company with Next Frontier Pharmaceuticals, Inc. ("Next Frontier"). Under the terms of the merger agreement, Next Frontier stockholders will be entitled to receive convertible stock of JUPW that is convertible into 65,000,000, shares of JUPW common stock. If you own JUPW shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/jupw
Terminix Global Holdings, Inc. TMX
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Terminix Global Holdings, Inc. TMX, in connection with the proposed acquisition of TMX by Rentokil Initial plc ("Rentokil Initial"). Under the terms of the merger agreement, TMX shareholders will receive approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American depository shares ("ADSs"), based on a 1:5 ADS to Rentokil Initial share ratio) and approximately $1.3 billion in cash. If you own TMX shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/tmx
CMC Materials, Inc. CCMP
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CMC Materials, Inc. CCMP in connection with the proposed acquisition of CCMP by Entegris, Inc. ("Entegris"). Pursuant to the merger agreement, CCMP stockholders will receive $133.00 in cash and 0.4506 shares of Entegris common stock for each share of CCMP common stock that they own, representing implied merger consideration of $192.52 based upon Entegris' January 5, 2022 closing price of $132.09. If you own CCMP shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/ccmp
Mimecast Limited MIME
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Mimecast Limited MIME, in connection with the proposed acquisition of MIME by Permira. Pursuant to the merger agreement, MIME shareholders will receive $80.00 in cash for each share of MIME common stock that they hold. If you own MIME shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/mime
SOURCE WeissLaw LLP
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.